Ringo's Gift seeds produce one of the most celebrated high-CBD cultivars available, combining Harle-Tsu and ACDC genetics to deliver CBD-to-THC ratios ranging from 1:1 to an impressive 24:1. The strain honors Lawrence Ringo, the late SoHum Seeds founder and pioneer of medical CBD breeding whose work transformed therapeutic cannabis. CBD concentrations reach 18% to 24% with minimal THC between 1% and 6%, producing profound therapeutic effects with little psychoactivity. Patients seeking relief without intoxication find this cultivar ideal, while experienced growers achieve flowering completion within 8 to 9 weeks producing yields up to 450 grams per square meter under proper indoor conditions.
Ringo's Gift originated at SoHum Seeds in Humboldt County, California, where breeders developed the strain as tribute to their late co-founder. The cultivar emerged during the early 2010s amid growing recognition of CBD's therapeutic potential, particularly for childhood epilepsy treatment. Its development reflected broader shifts in cannabis breeding priorities toward medical applications.
Lawrence Ringo championed CBD research years before mainstream acceptance, establishing breeding programs focused on high-CBD ratios when most cultivators chased maximum THC concentrations exclusively. His work directly influenced famous cultivars including Harle-Tsu and Sour Tsunami, both of which became foundation genetics for therapeutic cannabis. Ringo's contributions earned recognition throughout California's medical community.
Distribution through specialized medical dispensaries and seed banks has spread Ringo's Gift internationally over the past decade. Pediatric patients with treatment-resistant epilepsy and adults seeking non-intoxicating therapeutic options drove much of the early demand. Modern recognition extends well beyond the original medical community to include wellness-focused recreational consumers.
Lawrence Ringo co-founded SoHum Seeds in Humboldt County, building the operation into one of California's most respected medical cannabis breeding houses. His decades of work spanned both cultivation and breeding, with particular emphasis on developing genetics suitable for serious medical conditions rather than recreational use alone.
His research into cannabinoid therapy during the 2000s produced groundbreaking high-CBD genetics including Harle-Tsu and Sour Tsunami. These cultivars became foundational material for subsequent CBD breeding programs throughout California and beyond, influencing the broader development of medical cannabis worldwide. His passing in 2014 left behind stable genetic lines that continue helping patients today.
Ringo's Gift presents an unusual cannabinoid profile featuring dominant CBD with minimal THC across all phenotype expressions. Total cannabinoid concentrations reach the upper range among cannabis varieties, with some samples exceeding 25% combined CBD and minor cannabinoids. This high overall cannabinoid presence supports robust entourage effects.
CBD-to-THC ratios vary significantly between phenotypes, ranging from balanced 1:1 expressions to extreme 24:1 ratios suitable for pediatric medical applications. Lower-ratio phenotypes provide mild psychoactivity that some adult patients prefer, while higher ratios eliminate psychoactive effects almost entirely. Cultivators select specific phenotypes based on intended therapeutic applications.
Minor cannabinoids including CBG and CBC appear in significant quantities, contributing to the entourage effect that distinguishes Ringo's Gift from CBD isolate products. Laboratory testing has become standard for commercial Ringo's Gift production given the medical applications, with verified cannabinoid profiles supporting consistent therapeutic outcomes for patients depending on the cultivar.
The phenotype variation in Ringo's Gift creates distinct medical applications based on individual CBD-to-THC ratios. Patients select specific phenotypes matching their therapeutic needs, with some preferring mild psychoactivity while others requiring complete elimination of THC effects. Verified laboratory testing confirms phenotype identity in commercial markets.
| Phenotype | CBD:THC Ratio | Recommended Use |
|---|---|---|
| Phenotype 1:1 balanced | 1:1 ratio | Adults seeking mild effects with relief |
| Phenotype 4:1 mild psychoactivity | 4:1 ratio | Anxiety with subtle uplift desired |
| Phenotype 8:1 minimal high | 8:1 ratio | Pain relief with minimal impairment |
| Phenotype 12:1 medical focus | 12:1 ratio | Chronic conditions with daytime use |
| Phenotype 18:1 daytime use | 18:1 ratio | Working adults requiring full function |
| Phenotype 24:1 pediatric grade | 24:1 ratio | Children with epilepsy and seizure disorders |
Ringo's Gift offers minimal psychoactivity that allows daytime consumption without impairment of work, driving, or other demanding activities. Patients maintain mental clarity and productivity while experiencing meaningful symptom relief, distinguishing this cultivar from THC-dominant medical alternatives. Long-term therapy proves more sustainable.
Deep muscle relaxation occurs without the sedation typical of indica-dominant strains. Patients experience tension relief in shoulders, back, and other affected areas while remaining alert and capable of normal activities. This unique combination explains the strain's growing popularity among working adults managing chronic conditions through cannabis-based therapy.
Tolerance development occurs more slowly with CBD-dominant strains than with THC-dominant alternatives, supporting sustained therapeutic benefits over months and years of regular use. Patients can typically maintain consistent dosing without escalation, simplifying long-term treatment planning and reducing the financial burden of ongoing cannabis-based therapy considerably.
Physical relaxation occurs without the heaviness or numbness common to indica-dominant strains. Users describe a comfortable lightness throughout the body that supports continued activity while relieving tension and discomfort. This balanced physical effect distinguishes Ringo's Gift from purely sedative alternatives in the medical cannabis category.
Mental clarity persists throughout the experience, allowing patients to maintain work performance, drive safely, and engage normally with family and friends. Mild mood elevation typically begins 30 to 45 minutes after consumption, providing subtle uplift without euphoria or impaired judgment. Pain reduction develops gradually over the first hour for sustained relief.
Ringo's Gift cultivation rates as moderate difficulty without unusual challenges that complicate other specialty genetics. The strain handles standard growing conditions well, supporting reliable harvests for cultivators with basic experience. Disease resistance compares favorably to most commercial varieties, reducing pest management complexity considerably.
Plants reach 100 to 140 cm indoors with predictable growth patterns and manageable stretch during early flowering. Container size influences final plant dimensions significantly, with 20-liter pots producing optimal balance between plant size and resource efficiency. Smaller containers limit growth while larger pots offer diminishing returns relative to space costs.
Flowering completes consistently in 8 to 9 weeks under standard 12/12 lighting schedules. Yield potential reaches 450 grams per square meter under optimal indoor conditions, somewhat lower than THC-dominant commercial hybrids but acceptable for medical applications where cannabinoid quality matters more than absolute weight production. Stress avoidance preserves CBD-dominant expression effectively.
Suitable outdoor zones include warm sunny climates with dry autumns, encompassing Mediterranean regions and similar latitudes worldwide. Plants placed in the ground from May through June after the last frost develop strong structures supporting substantial harvests. Northern hemisphere harvests occur in early October typically.
Resistance to moderate temperature fluctuations and brief drought conditions makes Ringo's Gift relatively forgiving for outdoor cultivation. Late autumn rainfall protection becomes critical during the final weeks of flowering to preserve bud quality, with greenhouse coverage or temporary shelters protecting maturing flowers from weather damage during sensitive ripening periods.
Ringo's Gift produces moderate yields by commercial standards, reflecting the priorities of medical breeding rather than maximum output. Quality and cannabinoid profile matter more than gross weight for therapeutic applications, justifying the somewhat reduced yields compared to THC-focused commercial hybrids.
Cultivation parameters remain forgiving compared to specialty landrace genetics, allowing reasonable success across various indoor and outdoor configurations. Beginners can achieve respectable harvests with attention to basics, while experienced cultivators optimize through advanced techniques without facing genetic limitations that would compromise their efforts.
| Growing Parameter | Indoor Specifications | Outdoor Specifications |
|---|---|---|
| Flowering time | 8-9 weeks | Early to mid-October |
| Yield per square meter | 400-450 grams per square meter | N/A indoor metric |
| Yield per outdoor plant | N/A outdoor metric | 500-700 grams per plant |
| Plant height range | 100-140 cm | 180-220 cm |
| Harvest period outdoors | N/A indoor metric | Late September to mid-October |
| Difficulty level | Moderate | Moderate |
| Disease resistance rating | Above average | Above average |
Availability of Ringo's Gift seeds remains somewhat limited compared to mainstream commercial hybrids, reflecting the specialty medical market it serves. Specialized seed banks focusing on therapeutic cannabis offer the most reliable sources, though several mainstream vendors now stock Ringo's Gift due to growing demand. Verification of genetic authenticity matters particularly given medical applications.
Feminized versions dominate available offerings since most patients prioritize useful crop space and consistent results. Pack sizes range from 3 seeds for personal medical cultivation through 10 or more seeds for serious projects. Pricing exceeds commercial averages, typically reaching 12 to 20 USD per seed, reflecting the specialty nature of high-CBD genetics.
Laboratory testing has become standard for serious Ringo's Gift production given the medical implications of cannabinoid profile. Reputable vendors publish testing results showing CBD-to-THC ratios for their specific genetic stock, allowing patients to select phenotypes matching their therapeutic needs. Stealth shipping protects international orders from customs interception.
Ringo's Gift connects to a network of medical-focused and therapeutic cannabis varieties that share emphasis on patient welfare over recreational potency. The cultivars below offer related options worth exploring for medical patients building therapeutic libraries or growers expanding into specialty CBD genetics alongside more traditional offerings.
We've reserved a special discount on your first SEEDS order — but it expires soon.